Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BG-102 by SL Bigen for Obesity: Likelihood of Approval
BG-102 is under clinical development by SL Bigen and currently in Phase II for Obesity. According to GlobalData, Phase II...